Analysen von Matthew Weston

16.09.24 Roche Neutral UBS AG
10.09.24 Roche Neutral UBS AG
09.09.24 Roche Neutral UBS AG
26.07.24 Roche Neutral UBS AG
19.07.24 Sartorius vz. Neutral UBS AG
10.07.24 Roche Neutral UBS AG
10.07.24 Sartorius vz. Neutral UBS AG
09.07.24 Roche Neutral UBS AG
04.07.24 Roche Neutral UBS AG
02.07.24 Sartorius vz. Neutral UBS AG
20.06.24 Roche Neutral UBS AG
20.06.24 Sartorius vz. Neutral UBS AG
31.05.24 Roche Neutral UBS AG
17.05.24 Roche Neutral UBS AG
16.05.24 Sartorius vz. Neutral UBS AG
14.05.24 Roche Neutral UBS AG
25.04.24 Roche Neutral UBS AG
24.04.24 Roche Neutral UBS AG
18.04.24 Roche Neutral UBS AG
18.04.24 Sartorius vz. Neutral UBS AG
17.04.24 Sartorius vz. Neutral UBS AG
09.04.24 Roche Neutral UBS AG
20.03.24 Roche Neutral UBS AG
14.03.24 Sartorius vz. Neutral UBS AG
22.02.24 Roche Neutral UBS AG
05.02.24 Roche Neutral UBS AG
01.02.24 Roche Neutral UBS AG
31.01.24 Roche Neutral UBS AG
29.01.24 Sartorius vz. Neutral UBS AG
25.01.24 Sartorius vz. Neutral UBS AG
15.01.24 Sartorius vz. Neutral UBS AG
15.01.24 Roche Neutral UBS AG
18.04.23 Sartorius vz. Neutral Credit Suisse Group
16.10.20 Roche Neutral Credit Suisse Group
08.10.20 Roche Neutral Credit Suisse Group
24.07.20 Roche Neutral Credit Suisse Group
23.04.20 Roche Neutral Credit Suisse Group
25.11.19 Novartis Neutral Credit Suisse Group
25.04.19 Novartis Neutral Credit Suisse Group
05.04.19 Novartis Neutral Credit Suisse Group
25.02.19 Roche Neutral Credit Suisse Group
31.01.19 Novartis Neutral Credit Suisse Group
28.01.19 Roche Neutral Credit Suisse Group
19.10.18 Novartis Neutral Credit Suisse Group
09.08.18 Novo Nordisk Neutral Credit Suisse Group
19.07.18 Novartis Neutral Credit Suisse Group
18.04.18 Roche Neutral Credit Suisse Group
24.01.18 Novartis Neutral Credit Suisse Group
31.10.16 Novo Nordisk Neutral Credit Suisse Group
08.08.16 Novo Nordisk Neutral Credit Suisse Group